<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="viruses were analyzed for phylogeny and mutations. Neuraminidase inhibition and" exact="hemagglutination" post="inhibition assays were utilized to characterize the isolates. Results"/>
 <result pre="monitoring influenza-infected immunocompromised patients in general hospitals for the early" exact="detection" post="of emerging neuraminidase inhibitor-resistant viruses and maintaining continuous laboratory"/>
 <result pre="Man Background Neuraminidase inhibitors (NAIs) are globally utilized for the" exact="treatment" post="and prevention of influenza types A and B infection"/>
 <result pre="the treatment and prevention of influenza types A and B" exact="infection" post="[1], which are stockpiled by some countries, including the"/>
 <result pre="including drug resistance, since 2000. The KCDC carries out diagnostic" exact="testing" post="for influenza viruses in respiratory specimens requested by general"/>
 <result pre="Health Organization (WHO)) [6]. Flusurver provides genetic analysis tools for" exact="screening" post="drug-resistance and variant mutations to facilitate genetic characterization of"/>
 <result pre="cases in which influenza virus was continuously detected following NAI" exact="treatment" post="of hospitalized, immunosuppressed patients, rather than in clinical outpatients"/>
 <result pre="IPC Forward AGATTTGGACCTGCGAGCG GAPDH (65) Reverse GAGCGGCTGTCTCCACAAGT Probe Cy5-TTCTGACCTGAAGGCTCTGCGCG-BHQ Virus" exact="isolation" post="in MDCK cell lines Madin-Darby canine kidney (MDCK, American"/>
 <result pre="(N1) 1036â€&quot;1057 CTATCCAAACACCATTGCCGTA A-uni-NA-1442R NA 1407â€&quot;1442 ATATGGTCTCGTATTAGTAGAAACAAGGAGTTTTTT Genetic characterization Genetic" exact="screening" post="for drug resistance in the NA gene and mutational"/>
 <result pre="treated with receptor-destroying enzyme (Denka Seiken, Tokyo, Japan). Results A(H1N1)pdm09" exact="detection" post="and isolation in immunocompromised patients Influenza A virus was"/>
 <result pre="receptor-destroying enzyme (Denka Seiken, Tokyo, Japan). Results A(H1N1)pdm09 detection and" exact="isolation" post="in immunocompromised patients Influenza A virus was detected in"/>
 <result pre="29, respectively. A(H1N1)pdm09 viruses were identified by additional H1 subtype" exact="detection" post="at respective Ct values of 28 and 29 (TableÂ"/>
 <result pre="The isolates were named A/Korea/S0002/2019 and A/Korea/S0003/2019. Table 3 A(H1N1)pdm09" exact="virus detection" post="in immunocompromised patients by real-time RT-PCR Patient Genetic detection"/>
 <result pre="isolates were named A/Korea/S0002/2019 and A/Korea/S0003/2019. Table 3 A(H1N1)pdm09 virus" exact="detection" post="in immunocompromised patients by real-time RT-PCR Patient Genetic detection"/>
 <result pre="virus detection in immunocompromised patients by real-time RT-PCR Patient Genetic" exact="detection" post="using real-time RT-PCR IFV A IFV B A/H1 A/H3"/>
 <result pre="UD* 32.1/34.0 UD*: undetected Genetic characterization NA genetic analysis for" exact="screening" post="drug resistance, phylogeny, and variation The sequences of the"/>
 <result pre="no competing interests. References References 1.CooperNJSuttonAJAbramsKRWailooATurnerDNicholsonKGEffectiveness of neuraminidase inhibitors in" exact="treatment" post="and prevention of influenza a and B: systematic review"/>
 <result pre="associated with reduced inhibition by neuraminidase inhibitors (NAI)Laboratory methodologies for" exact="testing" post="the antiviral susceptibility of influenza viruses: Neuraminidase inhibitors (NAI)2018"/>
 <result pre="Mar 2016. 8.NguyenHTFryAMGubarevaLVNeuraminidase inhibitor resistance in influenza viruses and laboratory" exact="testing" post="methodsAntivi Ther20121715917310.3851/IMP2067 9.WeinstockDMGubarevaLVZuccottiGProlonged shedding of multidrug-resistant influenza a virus"/>
 <result pre="Health Organization; 2016. 16.collab: World Health OrganizationManual for the laboratory" exact="diagnosis" post="and virological surveillance of influenza2011 17.Okomo-AdhiamboMSleemanKBallengerKNguyenHTMishinVPSheuTGet al.Neuraminidase inhibitor susceptibility"/>
 <result pre="diagnosis and virological surveillance of influenza2011 17.Okomo-AdhiamboMSleemanKBallengerKNguyenHTMishinVPSheuTGet al.Neuraminidase inhibitor susceptibility" exact="testing" post="in human influenza viruses: a laboratory surveillance perspectiveViruses.201022269228910.3390/v210226921994620 18.MemoliMJAthotaRReedSCzajkowskiLBristolTProudfootKet"/>
 <result pre="a laboratory surveillance perspectiveViruses.201022269228910.3390/v210226921994620 18.MemoliMJAthotaRReedSCzajkowskiLBristolTProudfootKet al.The natural history of influenza" exact="infection" post="in the severely immunocompromised vs nonimmunocompromised hostsClin Infect Dis20135821422410.1093/cid/cit72524186906"/>
</results>
